External broker reports(aggregated public sources), Hong Leong Investment Bank Berhad

Hong Leong Investment Bank Berhad

Hong Leong Investment Bank Berhad operates as an investment banking company. The Company provides debt and equity funding, private debt securities issuance, merger and acquisitions, initial public offerings, corporate restructuring, and stockbroking services. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Equity Bottom-Up

<ul><li>Pharmaniaga reported core PATAMI of RM5.7m (+1.1% QoQ, -22.7% YoY) in 2Q23, bringing 1H23’s sum to RM11.4m (-71.9% YoY).</li><li>Results were a miss, accounting for merely 35% of ours and 27% of consensus projections.</li><li>The weaker-than-expected performance was due to burgeoning financing costs, on the back of increased borrowings. </li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Pharmaniaga reported core PATAMI of RM5.7m (+1.1% QoQ, -22.7% YoY) in 2Q23, bringing 1H23’s sum to RM11.4m (-71.9% YoY).Results were a miss, accounting for merely 35% of ours and 27% of consensus projections.The weaker-than-expected performance was due to burgeoning financing costs, on the back of increased borrowings. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Pharmaniaga - Weighed Down by Higher Financing Cost

Pharmaniaga Berhad

Pharmaniaga - Weighed Down by Higher Financing Cost